0001899779-22-000004.txt : 20221114 0001899779-22-000004.hdr.sgml : 20221114 20221114144718 ACCESSION NUMBER: 0001899779-22-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 EFFECTIVENESS DATE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Battle Financial, Inc. CENTRAL INDEX KEY: 0001899779 IRS NUMBER: 863370985 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-458256 FILM NUMBER: 221383975 BUSINESS ADDRESS: STREET 1: 2 ARBOR ROAD CITY: ST. LOUIS STATE: MO ZIP: 63132 BUSINESS PHONE: (970) 200-2907 MAIL ADDRESS: STREET 1: 2 ARBOR ROAD CITY: ST. LOUIS STATE: MO ZIP: 63132 D/A 1 primary_doc.xml X0708 D/A LIVE 0001899779 Battle Financial, Inc. 2 ARBOR ROAD ST. LOUIS MO MISSOURI 63132 (970) 200-2907 DELAWARE None None Corporation true 2021 Francis Trotter III 2 Arbor Road St. Louis MO MISSOURI 63132 Executive Officer Director Promoter President and Chief Executive Officer Arthur Richards Rule IV 2 Arbor Road St. Louis MO MISSOURI 63132 Director Promoter Melissa Larkin 2 Arbor Road St. Louis MO MISSOURI 63132 Executive Officer Chief Financial Officer Vincent Amato 2 Arbor Road St. Louis MO MISSOURI 63132 Executive Officer Chief Operating Officer Jeremy Jameson 2 Arbor Road St. Louis MO MISSOURI 63132 Executive Officer Chief Credit Officer Other Banking and Financial Services Decline to Disclose 06b true 0001899779-22-000003 2022-09-01 false true false 0 38500000 11032950 27467050 Additional shares of common stock will be issued and sold in this offering pursuant to firm purchase commitments upon satisfaction of conditions. false 45 0 0 800000 true Estimate represents payments of salaries to related persons for services in the ordinary course of business for 12 months from the date of the offering. Future salaries and payments are expected to be drawn from operating revenue. false Battle Financial, Inc. /s/ Francis O. Trotter III Francis Trotter III President and CEO 2022-11-14